Radiant Innovation (3373) - Total Assets
Based on the latest financial reports, Radiant Innovation (3373) holds total assets worth NT$861.31 Million TWD (≈ $27.14 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Radiant Innovation investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Radiant Innovation - Total Assets Trend (2017–2025)
This chart illustrates how Radiant Innovation's total assets have evolved over time, based on quarterly financial data. Check 3373 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Radiant Innovation - Asset Composition Analysis
Current Asset Composition (December 2025)
Radiant Innovation's total assets of NT$861.31 Million consist of 75.5% current assets and 24.5% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 15.6% |
| Accounts Receivable | NT$42.00 Million | 4.9% |
| Inventory | NT$441.01 Million | 51.2% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$0.00 | 0.0% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2017–2025)
This chart illustrates how Radiant Innovation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 3373 company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Radiant Innovation's current assets represent 75.5% of total assets in 2025, an increase from 74.3% in 2017.
- Cash Position: Cash and equivalents constituted 15.6% of total assets in 2025, down from 22.1% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2017.
- Asset Diversification: The largest asset category is inventory at 51.2% of total assets.
Radiant Innovation Competitors by Total Assets
Key competitors of Radiant Innovation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥912.83 Million |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$123.37 Million |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
|
China | CN¥3.71 Billion |
|
Dirui Industrial Co Ltd
SHE:300396
|
China | CN¥2.62 Billion |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
Radiant Innovation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 9.69 | 10.48 | 3.84 |
| Quick Ratio | 3.11 | 3.40 | 2.49 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$582.85 Million | NT$654.43 Million | NT$1.12 Billion |
Radiant Innovation - Advanced Valuation Insights
This section examines the relationship between Radiant Innovation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.00 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | -7.9% |
| Total Assets | NT$861.31 Million |
| Market Capitalization | $25.20 Million USD |
Valuation Analysis
Below Book Valuation: The market values Radiant Innovation's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Radiant Innovation's assets decreased by 7.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Radiant Innovation (2017–2025)
The table below shows the annual total assets of Radiant Innovation from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | NT$861.31 Million ≈ $27.14 Million |
-7.92% |
| 2024-12-31 | NT$935.42 Million ≈ $29.47 Million |
-4.48% |
| 2023-12-31 | NT$979.30 Million ≈ $30.85 Million |
-12.31% |
| 2022-12-31 | NT$1.12 Billion ≈ $35.18 Million |
-9.96% |
| 2021-12-31 | NT$1.24 Billion ≈ $39.07 Million |
-35.56% |
| 2020-12-31 | NT$1.92 Billion ≈ $60.64 Million |
+145.73% |
| 2019-12-31 | NT$783.22 Million ≈ $24.68 Million |
-1.65% |
| 2018-12-31 | NT$796.34 Million ≈ $25.09 Million |
-1.06% |
| 2017-12-31 | NT$804.84 Million ≈ $25.36 Million |
-- |
About Radiant Innovation
Radiant Innovation Inc. engages in the design and development of infrared technology products in Taiwan, Japan, and Germany. It offers medical infrared thermometers, including infrared ear, non-contact forehead, and multi-function thermometers, as well as probe cover; and CO2 monitors. The company also offers industrial infrared thermometers, infrared precision thermal imagers, infrared precision… Read more